Samsung partners with Quintiles to foray into biopharma market
by on Monday, February 28th, 2011 | No Comments
… Corporation (10%). Samsung plans to expand into producing copies of biologics including Rituxan, the leukemia and lymphoma treatment sold by Roche Holding and Biogen Idec. The company will also …
Go here to read the rest: Samsung partners with Quintiles to foray into biopharma market